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  24 
Capsule summary 25 
In this birth cohort, peanut allergy started in early childhood and persisted until young adult life. Allergic 26 
sensitization to peanut rose gradually from early childhood, with a rapid increase during adolescence; 27 
the latter being mostly asymptomatic.  28 
 29 
Key Words: 30 
Peanut Allergy, peanut allergen sensitization, natural history, birth cohort 31 
 32 
  33 
Arshad et al 3 
 
 34 
To the editor, 35 
Information on the natural history of peanut allergic sensitization (PAS) and clinical peanut 36 
allergy (PA) remains limited. Most previous studies selected children who were diagnosed with PA, 37 
which does not provide the population perspective and probably ignores those with low levels of 38 
sensitization.1,2 There are no population based studies on the natural history of PAS or PA. To provide a 39 
population perspective, we used the Isle of Wight (IoW) birth cohort (n=1,456) and determined the 40 
natural history of PAS and PA, focusing on incidence, persistence and remission. At 1, 2, 4, 10 and 18 41 
years, validated questionnaires were completed to obtain information on allergic symptoms, including 42 
peanut allergic reactions. Skin prick test (SPT) were carried out to 14 aero- and food allergens, including 43 
peanut at ages 4, 10 and 18 years in all consenting participants and at 1 and 2 years in those with allergic 44 
symptoms.3 Allergic sensitization was defined as a mean weal diameter of 3 mm greater than the 45 
negative control to an allergen on SPT. The diagnosis of PA was based on a convincing clinical history 46 
(one or more recognized allergic symptoms developing within 2 hours of food ingestion) plus evidence 47 
of sensitization to peanut on SPT. We used the term PAS, where SPT was positive to peanut irrespective 48 
of clinical reactivity.  49 
Details of experimental methods used and statistical analyses are provided in the online 50 
supplement of this article. Briefly, prevalence and their 95% confidence intervals were calculated. 51 
Means of SPT wheal sizes in those with persistent and remittent sensitization were compared using T 52 
test. Figure E1 (see online repository) provides information on data at each assessment. Details of each 53 
child sensitized to peanut at age 4, 10 and 18 years is provided in table E1, while table E2 provides a 54 
complete picture with imputed data (see online repository).  55 
PAS increased gradually in the first decade of life but showed a steeper rise from 10 to 18 years 56 
(Fig 1a).  At age 4 years, 13 of 976 children (1.3%, 95% confidence intervals (CI): 0.8%-2.3%) were 57 
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sensitized to peanut.  This increased to 19 of 1034 (1.8%, 95% CI: 1.2%-2.9%) at age 10 years with a 58 
further increase to 54 out of 851 (6.4%, 95% CI: 4.9-8.2%) at age 18 years. Previous studies have 59 
reported a similar prevalence of PAS varying from 1.1% to 8.6%.4,5 We show that this is primarily age 60 
dependent and varies from 1.3% in early childhood to 6.8% in adolescence (Fig 1b). At age 1 and 2, only 61 
those children reporting allergic symptoms were skin prick tested and hence the prevalence could have 62 
been overestimated. However, prevalence figures at age 1 and 2 are similar to those reported previously 63 
in another unselected birth cohort on the IoW.6 All peanut sensitized children had positive reactions to 64 
at least one aeroallergen with grass pollen sensitization being more common than tree pollen (Table E3). 65 
Cross-reactivity of peanut and grass pollen has been reported previously.7 At 4 years, eczema was the 66 
major co-morbidity, while at 10 and 18 years, rhinitis was present in the majority of peanut sensitized 67 
children.   68 
The most common pattern of peanut sensitization was its development for the first time at 18 69 
years; in 42 of 66 children (63.6%, 95% CI: 51.6%-74.2%) in association with grass pollen sensitivity and 70 
allergic rhinitis (Table 1 & E3). The other common pattern was persistent sensitization from age 4 (n=9) 71 
or 10 (n=6) years (15 of 66 or 22.7%, 95% CI: 14.3%-34.2%). However, other patterns where sensitization 72 
was transient or recurrent were observed in 9 of 66 (13.6%, 95% CI: 73.5%-23.9%) children. The mean 73 
difference in wheal size of 1.1 mm between persistence (mean; 4.4, SD: 2.0) and transient group (mean; 74 
3.3, SD: 0.4) failed to reach statistical significance (p=0.06).  75 
There was minimal change in the overall prevalence of PA beyond early childhood and it 76 
remained around 0.6% (Fig 1b). New onset of PA was uncommon at 10 years (1 of 6) but more common 77 
at 18 years (3 of 6). Remission of PA was seen in 1 of 6 (17%) between ages 4 to 10 years and 1 of 4 78 
(25%) from age 10 to 18 years (Table E4). The numbers with PA in our study were small and therefore, 79 
these findings should be interpreted with caution. However, the development of natural tolerance in a 80 
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small proportion is consistent with previous reports.1 We did not observe recurrence of PA, although 81 
one patient had recurrence of PAS after initial loss of SPT reactivity (Table 1). 82 
The diagnosis of PA can be questioned as oral challenge was not performed. However, a history 83 
of acute clinical reaction and evidence of allergic sensitization is considered adequate for the diagnosis 84 
in most cases.8 Moreover, we have previously shown that even a 3mm wheal has about 75% positive 85 
predictive value for PA if symptoms are present.9 Another limitation was missing information for SPT, 86 
which is inevitable in a long-term study, which spans over 20 years. 87 
Sensitization to peanut in early childhood was more commonly associated with clinical reactivity 88 
than during adolescence. Of those with sensitization at 4 year (n=10), 4 (40%) developed PA, while at 89 
age 18, only 2 of 42 (4.76%) children with new-onset sensitization developed PA (P=0.009). Thus, the 90 
increase in the number of subjects sensitized to peanut during adolescence was largely due to the onset 91 
of asymptomatic sensitization. 92 
In summary, in this cohort, PA started early in childhood and persisted in most children until 93 
adult life. A few adolescents did have new-onset PA compensating for those who remitted and therefore 94 
the overall prevalence remained around 0.6%. The natural history of PAS differed from that of PA in that 95 
it increased gradually from early childhood, with a significant peak incidence during adolescence. Most 96 
of this new onset sensitization to peanut was asymptomatic and associated with pollen sensitization and 97 
allergic rhinitis. The numbers with peanut allergy were small and thus generalizability of these findings is 98 
uncertain. Similar assessments in other longitudinally followed birth cohorts will clarify developmental 99 
patterns of PAS and PA during childhood.  100 
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 144 
Figure Legend 145 
Figure 1a: Sensitization to peanut on skin prick test from 1 to 18 years of age.  146 
Sensitization was defined as a positive SPT to peanut. Numbers above each point represent % of 147 
participants with sensitization at each assessment point.   148 
 149 
Figure 1b: Clinical allergy to peanut from 1 to 18 years 150 
Clinical allergy to peanut was defined as appearance of typical type I hypersensitivity symptoms within 2 151 
hours of exposure to peanut in participants with sensitization on SPT. Numbers above each point 152 
represent the % of participants with peanut allergy at each assessment. 153 
    154 
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 155 
Table 1: Natural history of sensitization to peanut during childhood. 156 
 157 
 158 
 159 
 160 
 161 
 162 
 163 
 164 
 165 
  166 
 Sensitized 
subjects 
SPT size at 4 
year 
SPT size at 10 
year 
SPT size at 18 
year 
Pattern of 
sensitization 
N=66 Median (IQ 
range 25-75) 
Median (IQ range 
25-75) 
Median (IQ range 
25-75) 
+++ 9 (13.6%) 3.5 (3.0-6.0) 4.5 (3.0-7.5) 5.50 (4.6-9.3) 
-++ 6 (9.1%) 0 3.5 (3.0-5.3) 3.50 (3.4-4.3) 
--+ 42 (63.6%) 0 0 4.0 (3.3-4.6) 
++- 2 (3.0%) 3.3 (3.0-3.5) 4.50 (3.0-6.0) 0 
+-- 4 (6.1%) 3.0 (3.0-3.8) 0 0 
+-+ 1 (1.5%) 4.0 0 3.8 
-+- 2 (3.0%) 0 3.0 (3.0-3.0) 0 
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On-line Supplement 167 
METHODS: 168 
Study setting:  169 
An unselected whole population birth cohort (n=1,536) was recruited in 1989 to prospectively study the 170 
natural history of allergic diseases. After exclusion of adoptions, perinatal deaths and refusal for follow-171 
up, 1,456 children were enrolled with follow-up assessments conducted at 1, 2, 4, 10 and 18 years.E1-E5 172 
The study was approved by the local ethics committee before recruitment and for each assessments. 173 
Informed consent was obtained from parents at age 1, 2, 4, 10 and from participants at age 18 years.   174 
Assessments:  175 
At each stage, validated questionnaires were completed to obtain information on allergic symptoms, 176 
including peanut allergic reactions. Questions about eating nuts were asked at age 4, 10 and 18 years. 177 
SPT were carried out to 14 aero- and food allergens, including peanut at ages 4, 10 and 18 years in all 178 
consenting participants and at 1 and 2 years in those with allergic symptoms (ALK-Abello, Horsholm, 179 
Denmark) as described before. Histamine (0.1 %) and physiological saline were used as positive and 180 
negative controls. A mean weal diameter at least 3 mm larger than that seen with saline after 15 181 
minutes was taken as a positive result.  182 
Definitions 183 
Allergic Sensitization: Allergic sensitization was defined as a mean weal diameter of 3 mm greater than 184 
the negative control to an allergen on SPT. Results were discounted if the positive control was not at 185 
least 3 mm in diameter. 186 
Peanut allergic sensitization (PAS): SPT positive to peanut irrespective of clinical history of a reaction. 187 
Clinical peanut Allergy (PA): The diagnosis of PA was based on a convincing clinical history verified by an 188 
allergist (SHA, RK, GR) plus evidence of allergic sensitisation to peanut. We required all 3 of the following 189 
criteria to be met; 190 
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1.  The report of one or more recognized allergic symptoms such as:E6  191 
a) localized: itching, sting/ burning of the lips/ mouth or throat, urticaria/ hives, 192 
angioedema 193 
b) abdominal: nausea, vomiting, crampy/ colicky abdominal pain, diarrhea 194 
c) respiratory: wheeze, stridor, watery rhinitis, redness of eyes/ nose 195 
d) skin: urticaria, itching, flushed skin, worsening eczema 196 
e) systemic reaction: anaphylaxis 197 
2. Temporal relationship of a reaction with symptoms developing within 2 hours of food ingestion. 198 
3. Positive SPT to peanut. 199 
Asymptomatic sensitization to peanut: Where SPT was positive to peanut but there was no evidence of 200 
a clinical reaction to peanut. 201 
Asthma: At 4 year follow-ups, the medical investigator determined the presence of asthma based on 202 
wheeze over the last 12 months and treatment given for asthma or asthma related symptoms. At the 10 203 
and 18 year follow-ups, asthma was defined as having “physician diagnosed asthma” and either 204 
“wheezing or whistling in the chest in the last 12 months” or “current treatment for asthma”, following 205 
the International Study of Asthma and Allergies in Childhood (ISAAC) criteria.E6  206 
Rhinitis was defined by an affirmative answer to “have you ever had a problem with sneezing, runny or 207 
blocked nose in the absence of cold or flu” plus “symptoms in the last 12 months”.E6 208 
Eczema was defined as chronic or chronically relapsing, itchy dermatitis lasting more than 6 weeks with 209 
characteristic morphology and distribution, following Hanifin and Rajka criteria.E7 210 
Statistical analysis 211 
Data were analysed using SPSS version 9. Means of SPT wheal sizes in those with persistent and 212 
remittent sensitization were compared using T test. Children were regarded as having “any sensitization 213 
to peanut” if SPT was positive to peanut at one or more assessment. When children developed PAS or 214 
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PA at 2 or 4 years, this was regarded as “Early childhood”. To provide a complete picture, data were 215 
imputed, replicating adjacent sensitization data, as shown in Table E2. Thus, missing data at 4 and 18 216 
years were imputed by that at 10 years (when most children were seen and had skin test.  217 
  218 
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 219 
Table E1: Natural history of sensitization to peanut during childhood (individual results). 220 
Subjects 4 year 10 year 18 year 
 Skin prick test mean wheal diameter (in mm) 
1 6.0 4.5 4.75 
2 3.5 3.0 5.0 
3 6.0 6.0 9.0 
4 3.0 4.5 5.5 
5 4.0 7.0 10.5 
6 3.0 8.0 Missing 
7 10.0 9.5 Missing 
8 Missing 3.0 4.5 
9 Missing 3.0 3.25 
10 0 6.0 3.5 
11 0 3.0 6.0 
12 0 5.0 3.5 
13 0 3.5 3.75 
14 0 3.0 Missing 
15 0 3.5 Missing 
16 3.5 6.0 0 
17 Missing 3.0 0 
18 4.0 0 0 
19 3.0 0 0 
20 3.0 0 0 
21 3.0 0 Missing 
22 4.0 0 3.75 
23 0 3.0 0 
24 0 3.0 0 
n=42* 13 missing 7 missing 3.0 – 7.5 
*At the age of 18 years, 42 subjects had new onset sensitization. However, 13 of these were not 221 
seen age 4 years and 7 were not seen at age 10 years. 222 
  223 
Arshad et al 15 
 
 224 
Table E2: Natural history of sensitization to peanut during childhood (individual results; with 225 
imputation of missing data)  226 
Subjects 4 year 10 year 18 year Pattern 
 Skin prick test mean wheal diameter (in mm)  
1 6.0 4.5 4.8 +++ 
2 3.5 3.0 5.0 +++ 
3 6.0 6.0 9.0 +++ 
4 3.0 4.5 5.5 +++ 
5 4.0 7.0 10.5 +++ 
6 3.0 8.0 8.0 +++ 
7 10.0 9.5 9.5 +++ 
8 3.0 3.0 4.5 +++ 
9 3.0 3.0 3.3 +++ 
10 0 6.0 3.5 -++ 
11 0 3.0 6.0 -++ 
12 0 5.0 3.5 -++ 
13 0 3.5 3.8 -++ 
14 0 3.0 3.0 -++ 
15 0 3.5 3.5 -++ 
16 3.5 6.0 0 ++- 
17 3.0 3.0 0 ++- 
18 4.0 0 0 +-- 
19 3.0 0 0 +-- 
20 3.0 0 0 +-- 
21 3.0 0 0 +-- 
22 4.0 0 3.8 +-+ 
23 0 3.0 0 -+- 
24 0 3.0 0 -+- 
N=42* 0 0 3.0-7.5 --+ 
*Those 42 subjects who had new onset sensitization at the age of 18 years were grouped 227 
together.  228 
Note: Imputation of missing data: For the first 24 subjects, missing data at 4 and 18 years were 229 
imputed by that obtained at 10 years. For those with new onset sensitization (n=42) at age 18 230 
years, missing SPT at age 4 and 10 years were presumed to be negative and regarded as zero.  231 
  232 
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 233 
Table E3: Associated allergic sensitization and clinical allergic conditions in those with peanut 234 
sensitization at each age. 235 
 236 
  237  4 year 10 year 18 year 
Peanut sensitization N=13 N=19 N=54 
Sensitization to any aeroallergen 11 (84.6%) 17 (89.5%) 52 (96.3%) 
Sensitization to grass pollen mix 6 (46.2%) 12 (63.2%) 47 (87.0%) 
Sensitization to tree pollen mix Not done 3 (15.8%) 27 (50.0%) 
Sensitization to any food allergen 3 (23.1%) 5 (26.3%) 48 (88.9%) 
Sensitization to wheat  0 3 (15.8%) 47 (87.0%) 
Sensitization to soya 1 (7.7%) 1 (5.3%) 4 (7.4%) 
Asthma 6 (46.2%) 6 (31.6%) 23 (42.6%) 
Eczema 8 (61.5%) 6 (31.6%) 7 (13.0%) 
Rhinitis 3 (23.1%) 10 (52.6%) 47 (87.0%) 
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 238 
 239 
 240 
Table E4: Natural history of clinical peanut allergy 241 
 242 
Subjects 4 year 10 year 18 year Nature of worst allergic reaction 
1 PA PA PA Oral symptoms, vomiting, urticaria 
and anaphylaxis  
2 PA PA PA Anaphylaxis within an hour of 
peanut ingestion 
3 PA PA PA Vomiting within an hour of peanut 
ingestion 
4 PA PA Missing Urticarial rash within one hour of 
peanut ingestion 
5 PA PA No PA Urticarial rash and throat tightness 
within an hour of peanut ingestion 
6 PA No PA No PA Urticaria within an hour of peanut 
ingestion 
7 No PA AS PA Immediate throat tightness, 
wheezing, generalized urticaria, 
anaphylaxis 
8 No PA No PA PA Urticaria and wheeze, progressing 
to anaphylaxis  
9 No PA No PA PA Anaphylaxis 
10 AS PA Missing 
(died) 
Immediate vomiting with peanut; 
died at age 11 of acute asthma 
attackE9 
PA= Peanut Allergy 243 
No PA= No Peanut Allergy 244 
AS= Asymptomatic sensitization 245 
Notes: Out of 6 cases of PA at age 4 years, 5 persisted to 10 years and one outgrew PA. Of these 5, 3 had 246 
persistent allergy to 18 years (one was not seen at 18 years and one outgrew PA).  247 
Allergic reaction to peanut caused typical symptoms including systemic manifestations or anaphylaxis. 248 
One child at 4, 2 at 10 and 4 at 18 years had given a history of anaphylactic reactions to peanut.  249 
All of these children had been given a diagnosis of asthma, eczema and rhinitis at some stage in their life 250 
except one child (subject 7 in Table 4) who did not have eczema. 251 
  252 
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